XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
12 Months Ended
Feb. 28, 2022
Dec. 10, 2021
Dec. 10, 2021
Oct. 14, 2020
Oct. 09, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Dec. 31, 2016
Loss Contingencies [Line Items]                  
Cash proceeds from sale of common stock           $ 2,338,349    
Purchase obligation           511,000 1,600,000    
Stock Issued During Period, Shares, Reverse Stock Splits       632 632        
Stockholders' Equity, Reverse Stock Split   5-for-1 reverse stock split     1-for-5 reverse stock split        
Maximum [Member]                  
Loss Contingencies [Line Items]                  
Cash proceeds from sale of common stock           150,000,000      
Harborside [Member]                  
Loss Contingencies [Line Items]                  
Stock Issued During Period, Shares, Reverse Stock Splits   1,000,000              
Stock Issued During Period, Shares, Stock Splits   200,000              
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 1,000,000              
Incurred damages amount   $ 75,000 $ 75,000            
Harborside [Member] | Maximum [Member]                  
Loss Contingencies [Line Items]                  
Loss Contingency, Damages Sought, Value     33,020,000            
Harborside [Member] | Minimum [Member]                  
Loss Contingencies [Line Items]                  
Loss Contingency, Damages Sought, Value     5,020,000            
Conversion Labs Rx Business [Member]                  
Loss Contingencies [Line Items]                  
Stock Issued During Period, Shares, Stock Splits   200,000              
Conversion Labs Rx Business [Member] | Maximum [Member]                  
Loss Contingencies [Line Items]                  
Stock Issued During Period, Shares, Stock Splits   1,000,000              
Subscription Agreement [Member]                  
Loss Contingencies [Line Items]                  
Accounts payable and accrued expenses           $ 0 $ 0    
Pilaris Laboratories LLC [Member]                  
Loss Contingencies [Line Items]                  
Finite-lived intangible asset, useful life                 10 years
Percentage of net income                 10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period               10 years  
Pilaris Laboratories LLC [Member] | CVLB PR [Member]                  
Loss Contingencies [Line Items]                  
Agreements of performance fees, description                 As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula: Net Income = total income – cost of goods sold – advertising and operating expenses directly related to the marketing of the licensed products.
MALPHABET LLC [Member]                  
Loss Contingencies [Line Items]                  
Agreements of performance fees, description               The Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products. No amounts were earned or owed as of December 31, 2021.  
Percentage for royalty.               13.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               20,000  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price               $ 2.50  
MALPHABET LLC [Member] | Common Stock One [Member]                  
Loss Contingencies [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               20,000  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price               $ 2.50  
Cash proceeds from sale of common stock               $ 7,500,000  
MALPHABET LLC [Member] | Common Stock Two [Member]                  
Loss Contingencies [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               20,000  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price               $ 2.50  
Cash proceeds from sale of common stock               $ 10,000,000  
MALPHABET LLC [Member] | Common Stock Three [Member]                  
Loss Contingencies [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               40,000  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price               $ 3.75  
Cash proceeds from sale of common stock               $ 20,000,000  
Conversion Labs Rx Business [Member] | Harborside [Member]                  
Loss Contingencies [Line Items]                  
Stock Issued During Period, Shares, Reverse Stock Splits   10,000,000              
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 5,000,000              
Conversion Labs Rx Business [Member] | Harborside [Member] | Maximum [Member]                  
Loss Contingencies [Line Items]                  
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 5,000,000              
Conversion Labs Rx [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency breach of contract amount     $ 273,859            
Blair L L C [Member] | Subsequent Event [Member]                  
Loss Contingencies [Line Items]                  
Loss contingency breach of contract amount $ 1,000,000